Combined use of hyperthermia and radiation therapy for treating locally advanced cervical cancer

oncology; radiation therapy; hyperthermia; gynecologic cancer; cervix carcinoma; treatment outcome; systematic review; Cochrane data base; oncologie; radiothérapie oncologie; hyperthermie; cancers gynécologiques; cancer du col utérin; tésultats thérapeutiques; revue systématique; base de données Cochrane

Abstract :

[en] Available data suggest that addition of hyperthermia to radiation therapy improves local tumour control and overall survival in patients with locally advanced (FIGO stage IIIB) cervix carcinoma without affecting treatment related grade 3 to 4 acute or late toxicity.

Disciplines :

Oncology

Author, co-author :

Lutgens, Ludy; Radiation Oncology, Maastro Clinic, 6229 ET Maastricht, Netherlands ; Maastricht 6202 AZ, Netherlands

Lammering, Guido; Maastro Clinic

Pijls-Johannesma, Madelon; Maastro Clinic

van der Zee, Jacoba; Academisch Ziekenhuis Rotterdam > Radiotherapie Hyperthermia

Lambin, Philippe; Maastro Clinic

Deneufbourg, Jean-Marie ; Université de Liège - ULiège > Département des sciences cliniques > Radiothérapie

De Ruysscher, Dirk K M; Maastro Clinic

Language :

English

Title :

Combined use of hyperthermia and radiation therapy for treating locally advanced cervical cancer

Publication date :

27 December 2007

Publisher :

Wiley and sons LTD, Londres, United Kingdom

Additional URL :

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006377/epdf/full

Available on ORBi :

since 11 May 2022

Statistics

Number of views

67 (5 by ULiège)

Number of downloads

37 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Brady 1976 Brady LW. Future prospects of radiotherapy in gynecologic oncology. Cancer 1976;38(Suppl 1):553-65. [MEDLINE: Abridged-Index-Medicus; Index-Medicus].
De Jaeger 1998 De Jaeger K, Merlo FM, Kavanagh MC, Fyles AW, Hedley D, Hill RP. Heterogeneity of tumor oxygenation: relationship to tumor necrosis, tumor size, and metastasis. International Journal of Radiation Oncology, Biology, Physics 1998;42(4):717-21. [MEDLINE: Index-Medicus].
De Wit 1999 de Wit R, van der Zee J, van der Burg ME, Kruit WH, Logmans A, van Rhoon GC, et al.A phase I/II study of combined weekly systemic cisplatin and locoregional hyperthermia in patients with previously irradiated recurrent carcinoma of the uterine cervix. British Journal of Cancer 1999;80(9):1387-91. [MEDLINE: Index-Medicus].
Dinges 1998 Dinges S, Harder C, Wurm R, Buchali A, Blohmer J, Gellermann J, et al.Combined treatment of inoperable carcinomas of the uterine cervix with radiotherapy and regional hyperthermia. Results of a phase II trial. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft [et al] 1998;174(10):517-21. [MEDLINE: Index-Medicus].
Eifel 1994 Eifel PJ, Morris M, Wharton JT, Oswald MJ. The influence of tumor size andmorphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. International Journal of Radiation Oncology, Biology, Physics 1994;29(1):9-16. [MEDLINE: Index-Medicus].
Fyles 1995 Fyles AW, Pintilie M, Kirkbride P, Levin W, Manchul LA, Rawlings GA. Prognostic factors in patients with cervix cancer treated by radiation therapy: results of a multiple regression analysis. Radiotherapy and Oncology Journal of the European Society for Therapeutic Radiology and Oncology 1995;35(2):107-17. [MEDLINE: Index-Medicus].
Fyles 1998 Fyles AW, Milosevic M, Wong R, Kavanagh MC, Pintilie M, Sun A, et al.Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiotherapy and Oncology Journal of the European Society for Therapeutic Radiology and Oncology 1998;48(2):149-56. [MEDLINE: Index-Medicus].
Haensgen 2001 Haensgen G, Krause U, Becker A, Stadler P, Lautenschlaeger C, Wohlrab W, et al.Tumor hypoxia, p53, and prognosis in cervical cancers. International Journal of Radiation Oncology, Biology, Physics 2001;50(4):865-72. [MEDLINE: Index-Medicus].
Haie 1988 Haie C, Pejovic MH, Gerbaulet A, Horiot JC, Pourquier H, Delouche J, et al.Is prophylactic para-aortic irradiation worthwhile in the treatment of advanced cervical carcinoma? Results of a controlled clinical trial of the EORTC radiotherapy group. Radiotherapy and Oncology Journal of the European Society for Therapeutic Radiology and Oncology 1988;11(2): 101-12. [MEDLINE: Index-Medicus].
Harima 2001 Harima Y, Nagata K, Harima K, Ostapenko VV, Tanaka Y, Sawada S. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. International Journal of Hyperthermia the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2001;17(2):97-105. [MEDLINE: Index-Medicus].
Hockel 1993 Hockel M, Knoop C, Schlenger K, Vorndran B, Baussmann E, Mitze M, et al.Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. Radiotherapy and Oncology Journal of the European Society for Therapeutic Radiology and Oncology 1993;26(1):45-50. [MEDLINE: Index-Medicus].
Hockel 1999 Hockel M, Schlenger K, Hockel S, Vaupel P.Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Research 1999;59(18):4525-8. [MEDLINE: Index-Medicus].
Horiot 1988 Horiot JC, Pigneux J, Pourquier H, Schraub S, Achille E, Keiling R, et al.Radiotherapy alone in carcinoma of the intact uterine cervix according to G. H. Fletcher guidelines: a French cooperative study of 1383 cases. International Journal of Radiation Oncology, Biology, Physics 1988;14(4):605-11. [MEDLINE: Index-Medicus].
Hornback 1986 Hornback NB, Shupe RE, Shidnia H, Marshall CU, Lauer T. Advanced stage IIIB cancer of the cervix treatment by hyperthermia and radiation. Gynecologic Oncology 1986;23(2):160-7. [MEDLINE: Index-Medicus].
Keys 1999 Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL, 3rd, et al.Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. New England Journal of Medicine 1999;340(15):1154-61. [MEDLINE: Ca27469canci; ca37517canci].
Khalil 1995 Khalil AA, Horsman MR, Overgaard J. The importance of determining necrotic fraction when studying the effect of tumour volume on tissue oxygenation. Acta Oncologica Stockholm (Stockholm, Sweden) 1995;34(3):297-300. [MEDLINE: Index-Medicus].
Lanciano 1991 Lanciano RM, Won M, Coia LR, Hanks GE. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies. International Journal of Radiation Oncology, Biology, Physics 1991;20(4):667-76. [MEDLINE: Ca15978canci; cm87275cmnci].
Mendenhall 1984 Mendenhall WM, Thar TL, Bova FJ, Marcus RB, Jr, Morgan LS, Million RR. Prognostic and treatment factors affecting pelvic control of Stage IB and IIA-B carcinoma of the intact uterine cervix treated with radiation therapy alone. Cancer 1984;53(12):2649-54. [MEDLINE: Abridged-Index-Medicus; Index-Medicus].
Milross 1997 Milross CG, Tucker SL, Mason KA, Hunter NR, Peters LJ, Milas L. The effect of tumor size on necrosis and polarographically measured pO2. Acta oncologica Stockholm, Sweden 1997;36(2):183-9. [MEDLINE: Ca06294canci].
Morris 1999 Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, et al.Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. New England Journal of Medicine 1999;340(15):1137-43. [MEDLINE: U10ca21661canci; u10ca32115canci].
Pearcey 2002 Pearcey R, Brundage M, Drouin P, Jeffrey J, Johnston D, Lukka H, et al.Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology 2002;20(4):966-72. [MEDLINE: Index-Medicus].
Perez 1998 Perez CA, Grigsby PW, Chao KS, Mutch DG, Lockett MA. Tumor size, irradiation dose, and long-termoutcome of carcinoma of uterine cervix. International Journal of Radiation Oncology, Biology, Physics 1998;41(2):307-17. [MEDLINE: Index-Medicus].
Rietbroek 1997 Rietbroek RC, Schilthuis MS, Bakker PJ, van Dijk JD, Postma AJ, Gonzalez Gonzalez D, et al.Phase II trial of weekly locoregional hyperthermia and cisplatin in patients with a previously irradiated recurrent carcinoma of the uterine cervix. Cancer 1997;79(5):935-43. [MEDLINE: Abridged-Index-Medicus; Index-Medicus].
Rose 1999 Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. New England Journal of Medicine 1999;340(15):1144-53. [MEDLINE: Ca27469canci; ca37517canci].
Rotman 1995 Rotman M, Pajak TF, Choi K, Clery M, Marcial V, Grigsby PW, et al.Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20. JAMA 1995;274(5):387-93. [MEDLINE: Ca21661canci; ca32115canci].
Stehman 1991 Stehman FB, Bundy BN, DiSaia PJ, Keys HM, Larson JE, Fowler WC. Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 1991;67(11):2776-85. [MEDLINE: Ca12534canci; ca27816canci; ca12484canci].
Stehman 1994 Stehman FB, Thomas GM. Prognostic factors in locally advanced carcinoma of the cervix treated with radiation therapy. Seminars in Oncology 1994;21(1):25-9. [MEDLINE: Index-Medicus].
Thomas 2001 Thomas G. The effect of hemoglobin level on radiotherapy outcomes: the Canadian experience. Seminars in Oncology 2001;28(2 Suppl 8):60-5. [MEDLINE: Index-Medicus].
Tsang 1995 Tsang RW, Fyles AW, Kirkbride P, Levin W, Manchul LA, Milosevic MF, et al.Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results. International Journal of Radiation Oncology, Biology, Physics 1995;32(5):1319-29. [MEDLINE: Index-Medicus].
van der Zee 2000 van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000;355(9210):1119-25. [MEDLINE: Abridged-Index-Medicus; Index-Medicus].
Vasanthan 2005 Vasanthan A, Mitsumori M, Park JH, Zhi Fan Z, Yu Bin Z, Oliynychenko P, et al.Regional hyperthermia combined with radiotherapy for uterine cervical cancers: A multi-institutional prospective randomized trial of the international atomic energy agency. International Journal of Radiation Oncology, Biology, Physics 2005;61(1):145-53. [MEDLINE: Index-Medicus].
Vaupel 2001 Vaupel P, Kelleher DK, Hockel M. Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. Seminars in Oncology 2001;28(2 Suppl 8):29-35. [MEDLINE: Index-Medicus].
Werner 1995 Werner Wasik M, Schmid CH, Bornstein L, Ball HG, Smith DM, Madoc Jones H. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma. International Journal of Radiation Oncology, Biology, Physics 1995;32(5):1309-17. [MEDLINE: Index-Medicus].
West 1995 West CM, Davidson SE, Burt PA, Hunter RD. The intrinsic radiosensitivity of cervical carcinoma: correlations with clinical data. International Journal of Radiation Oncology, Biology, Physics 1995;31(4):841-6. [MEDLINE: Index-Medicus].
Westermann 2005 Westermann AM, Jones EL, Schem BC, van der Steen Banasik EM, Koper P, Mella O, et al.First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma. Cancer 2005;104(4):763-70. [MEDLINE: P01ca4274516canci].
Whitney 1999 Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC, Jr, et al.Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology 1999;17(5):1339-48. [MEDLINE: Ca12484canci; ca12534canci; ca27816canci].